Correction to: OX40 in the Pathogenesis of Atopic Dermatitis—A New Therapeutic Target (American Journal of Clinical Dermatology, (2024), 25, 3, (447-461), 10.1007/s40257-023-00838-9)

Michael Croft; Ehsanollah Esfandiari; Camilla Chong; Hailing Hsu; Kenji Kabashima; Greg Kricorian; Richard B. Warren; Andreas Wollenberg; Emma Guttman-Yassky

doi:10.1007/s40257-024-00850-7

Correction to: OX40 in the Pathogenesis of Atopic Dermatitis—A New Therapeutic Target (American Journal of Clinical Dermatology, (2024), 25, 3, (447-461), 10.1007/s40257-023-00838-9)

Michael Croft, Ehsanollah Esfandiari, Camilla Chong, Hailing Hsu, Kenji Kabashima, Greg Kricorian, Richard B. Warren, Andreas Wollenberg, Emma Guttman-Yassky

Research output: Contribution to journal › Comment/debate

Abstract

Graphical abstract, right-hand panel “Targeting OX40 Signaling”: the labels OX40L and OX40 were incorrectly aligned. This alignment has been corrected. The original article has been corrected.

Original language	English
Pages (from-to)	463
Number of pages	1
Journal	American Journal of Clinical Dermatology
Volume	25
Issue number	3
DOIs	https://doi.org/10.1007/s40257-024-00850-7
State	Published - May 2024

Access to Document

10.1007/s40257-024-00850-7

Cite this

Croft, M., Esfandiari, E., Chong, C., Hsu, H., Kabashima, K., Kricorian, G., Warren, R. B., Wollenberg, A., & Guttman-Yassky, E. (2024). Correction to: OX40 in the Pathogenesis of Atopic Dermatitis—A New Therapeutic Target (American Journal of Clinical Dermatology, (2024), 25, 3, (447-461), 10.1007/s40257-023-00838-9). American Journal of Clinical Dermatology, 25(3), 463. https://doi.org/10.1007/s40257-024-00850-7

@article{37333a65028349a189a0df6dba60874a,

title = "Correction to: OX40 in the Pathogenesis of Atopic Dermatitis—A New Therapeutic Target (American Journal of Clinical Dermatology, (2024), 25, 3, (447-461), 10.1007/s40257-023-00838-9)",

abstract = "Graphical abstract, right-hand panel “Targeting OX40 Signaling”: the labels OX40L and OX40 were incorrectly aligned. This alignment has been corrected. The original article has been corrected.",

author = "Michael Croft and Ehsanollah Esfandiari and Camilla Chong and Hailing Hsu and Kenji Kabashima and Greg Kricorian and Warren, {Richard B.} and Andreas Wollenberg and Emma Guttman-Yassky",

note = "Publisher Copyright: {\textcopyright} Springer Nature Switzerland AG 2024.",

year = "2024",

month = may,

doi = "10.1007/s40257-024-00850-7",

language = "English",

volume = "25",

pages = "463",

journal = "American Journal of Clinical Dermatology",

issn = "1175-0561",

publisher = "Adis International Ltd",

number = "3",

}

Croft, M, Esfandiari, E, Chong, C, Hsu, H, Kabashima, K, Kricorian, G, Warren, RB, Wollenberg, A & Guttman-Yassky, E 2024, 'Correction to: OX40 in the Pathogenesis of Atopic Dermatitis—A New Therapeutic Target (American Journal of Clinical Dermatology, (2024), 25, 3, (447-461), 10.1007/s40257-023-00838-9)', American Journal of Clinical Dermatology, vol. 25, no. 3, pp. 463. https://doi.org/10.1007/s40257-024-00850-7

Correction to: OX40 in the Pathogenesis of Atopic Dermatitis—A New Therapeutic Target (American Journal of Clinical Dermatology, (2024), 25, 3, (447-461), 10.1007/s40257-023-00838-9). / Croft, Michael; Esfandiari, Ehsanollah; Chong, Camilla et al.
In: American Journal of Clinical Dermatology, Vol. 25, No. 3, 05.2024, p. 463.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction to

T2 - OX40 in the Pathogenesis of Atopic Dermatitis—A New Therapeutic Target (American Journal of Clinical Dermatology, (2024), 25, 3, (447-461), 10.1007/s40257-023-00838-9)

AU - Croft, Michael

AU - Esfandiari, Ehsanollah

AU - Chong, Camilla

AU - Hsu, Hailing

AU - Kabashima, Kenji

AU - Kricorian, Greg

AU - Warren, Richard B.

AU - Wollenberg, Andreas

AU - Guttman-Yassky, Emma

PY - 2024/5

Y1 - 2024/5

N2 - Graphical abstract, right-hand panel “Targeting OX40 Signaling”: the labels OX40L and OX40 were incorrectly aligned. This alignment has been corrected. The original article has been corrected.

AB - Graphical abstract, right-hand panel “Targeting OX40 Signaling”: the labels OX40L and OX40 were incorrectly aligned. This alignment has been corrected. The original article has been corrected.

UR - http://www.scopus.com/inward/record.url?scp=85184515749&partnerID=8YFLogxK

U2 - 10.1007/s40257-024-00850-7

DO - 10.1007/s40257-024-00850-7

M3 - Comment/debate

AN - SCOPUS:85184515749

SN - 1175-0561

VL - 25

SP - 463

JO - American Journal of Clinical Dermatology

JF - American Journal of Clinical Dermatology

IS - 3

ER -

Correction to: OX40 in the Pathogenesis of Atopic Dermatitis—A New Therapeutic Target (American Journal of Clinical Dermatology, (2024), 25, 3, (447-461), 10.1007/s40257-023-00838-9)

Abstract

Access to Document

Fingerprint

Cite this